A detailed history of Advisor Group Holdings, Inc. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 10,013 shares of KOD stock, worth $80,204. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,013
Previous 10,670 6.16%
Holding current value
$80,204
Previous $25,000 4.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.2 - $3.25 $1,445 - $2,135
-657 Reduced 6.16%
10,013 $26,000
Q2 2024

Aug 13, 2024

BUY
$2.29 - $4.48 $5,553 - $10,864
2,425 Added 29.41%
10,670 $25,000
Q1 2024

May 10, 2024

BUY
$3.01 - $7.45 $14,387 - $35,611
4,780 Added 137.95%
8,245 $43,000
Q4 2023

Feb 12, 2024

BUY
$1.4 - $3.24 $1,645 - $3,807
1,175 Added 51.31%
3,465 $10,000
Q3 2023

Nov 13, 2023

BUY
$1.8 - $7.49 $360 - $1,498
200 Added 9.57%
2,290 $4,000
Q2 2023

Aug 10, 2023

BUY
$4.3 - $9.48 $266 - $587
62 Added 3.06%
2,090 $14,000
Q1 2023

May 12, 2023

SELL
$4.81 - $8.88 $28 - $53
-6 Reduced 0.29%
2,028 $12,000
Q4 2022

Feb 10, 2023

BUY
$6.52 - $8.05 $652 - $805
100 Added 5.17%
2,034 $14,000
Q2 2022

Aug 10, 2022

BUY
$5.04 - $9.48 $2,520 - $4,740
500 Added 34.87%
1,934 $14,000
Q1 2022

May 04, 2022

BUY
$7.09 - $89.45 $9,557 - $120,578
1,348 Added 1567.44%
1,434 $11,000
Q2 2021

Aug 02, 2021

SELL
$77.2 - $126.54 $18,914 - $31,002
-245 Reduced 74.02%
86 $8,000
Q1 2021

May 13, 2021

SELL
$110.45 - $164.47 $777,568 - $1.16 Million
-7,040 Reduced 95.51%
331 $38,000
Q4 2020

Feb 10, 2021

BUY
$60.78 - $154.03 $429,775 - $1.09 Million
7,071 Added 2357.0%
7,371 $1.08 Million
Q3 2020

Nov 12, 2020

SELL
$45.05 - $59.27 $9,865 - $12,980
-219 Reduced 42.2%
300 $18,000
Q2 2020

Aug 14, 2020

BUY
$42.74 - $66.25 $5,983 - $9,275
140 Added 36.94%
519 $28,000
Q1 2020

May 18, 2020

BUY
$38.18 - $73.95 $14,470 - $28,027
379 New
379 $18,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $417M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.